Recessive COL6A2 C-globular Missense Mutations in Ullrich Congenital Muscular Dystrophy ROLE OF THE C2a SPLICE VARIANT


Autoria(s): ZHANG, Rui-Zhu; ZOU, Yaqun; PAN, Te-Cheng; MARKOVA, Dessislava; FERTALA, Andrzej; HU, Ying; SQUARZONI, Stefano; REED, Umbertina Conti; MARIE, Suely K. N.; BOENNEMANN, Carsten G.; CHU, Mon-Li
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

19/10/2012

19/10/2012

2010

Resumo

Ullrich congenital muscular dystrophy (UCMD) is a disabling and life-threatening disorder resulting from either recessive or dominant mutations in genes encoding collagen VI. Although the majority of the recessive UCMD cases have frameshift or nonsense mutations in COL6A1, COL6A2, or COL6A3, recessive structural mutations in the COL6A2 C-globular region are emerging also. However, the underlying molecular mechanisms have remained elusive. Here we identified a homozygous COL6A2 E624K mutation (C1 subdomain) and a homozygous COL6A2 R876S mutation (C2 subdomain) in two UCMD patients. The consequences of the mutations were investigated using fibroblasts from patients and cells stably transfected with the mutant constructs. In contrast to expectations based on the clinical severity of these two patients, secretion and assembly of collagen VI were moderately affected by the E624K mutation but severely impaired by the R876S substitution. The E624K substitution altered the electrostatic potential of the region surrounding the metal ion-dependent adhesion site, resulting in a collagen VI network containing thick fibrils and spots with densely packed microfibrils. The R876S mutation prevented the chain from assembling into triple-helical collagen VI molecules. The minute amount of collagen VI secreted by the R876S fibroblasts was solely composed of a faster migrating chain corresponding to the C2a splice variant with an alternative C2 subdomain. In transfected cells, the C2a splice variant was able to assemble into short microfibrils. Together, the results suggest that the C2a splice variant may functionally compensate for the loss of the normal COL6A2 chain when mutations occur in the C2 subdomain.

National Institutes of Health (NIH)[AR053251]

National Institutes of Health (NIH)[AR049537]

National Institutes of Health (NIH)[AR051999]

Muscular Dystrophy Association USA[3896]

Identificador

JOURNAL OF BIOLOGICAL CHEMISTRY, v.285, n.13, p.10005-10015, 2010

0021-9258

http://producao.usp.br/handle/BDPI/22225

10.1074/jbc.M109.093666

http://dx.doi.org/10.1074/jbc.M109.093666

Idioma(s)

eng

Publicador

AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC

Relação

Journal of Biological Chemistry

Direitos

restrictedAccess

Copyright AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC

Palavras-Chave #VON-WILLEBRAND-FACTOR #COLLAGEN ALPHA-3 CHAIN #BETHLEM MYOPATHY #CRYSTAL-STRUCTURE #VONWILLEBRAND-FACTOR #SEQUENCE-ANALYSIS #VI MUTATIONS #GENE CAUSES #A-DOMAINS #I-DOMAIN #Biochemistry & Molecular Biology
Tipo

article

original article

publishedVersion